JP Morgan Chase
ARKG icon

JP Morgan Chase’s ARK Genomic Revolution ETF ARKG Stock Holding History

JP Morgan Chase’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48M Hold
100,000
– – ﹤0.01% 3939
2025
Q4 		$2.9M Buy
+100,000
New +$3M ﹤0.01% 3792

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

JP Morgan Chase's ARKG Position: Q1 2026 in Review

JP Morgan Chase increased its ARK Genomic Revolution ETF (ARKG) stake by 40% in Q1 2026, buying an estimated $61M and bringing the position to 7,230,809 shares worth $179M. The position accounts for 0.01% of the portfolio, ranked #733.

JP Morgan Chase first reported a position in ARKG in Q4 2019 and has held it in 26 quarters since. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • JP Morgan Chase held 7,230,809 shares of ARK Genomic Revolution ETF worth $179M as of Q1 2026.
  • JP Morgan Chase bought 2,081,355 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $61M.
  • ARK Genomic Revolution ETF made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #733 holding.
  • JP Morgan Chase first reported a position in ARK Genomic Revolution ETF in Q4 2019 and has held it in 26 quarters since.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.